Durect Corp (STU:DC8A)
€ 0.81 0 (0%) Market Cap: 27.64 Mil Enterprise Value: 30.87 Mil PE Ratio: 0 PB Ratio: 24.82 GF Score: 49/100

Q4 2019 DURECT Corp Earnings Call Transcript

Mar 03, 2020 / 09:30PM GMT
Release Date Price: €14.9 (-2.61%)
Operator

Greetings, and welcome to the DURECT Corporation Fourth Quarter and Fiscal Year-end 2019 Earnings Conference call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Mike Arenberg, Chief Financial Officer. Thank you. You may begin.

Michael H. Arenberg
DURECT Corporation - CFO

Good afternoon, and welcome to our fourth quarter 2019 earnings conference call. This is Mike Arenberg, Chief Financial Officer of DURECT Corporation. I will provide a brief review of our financial results; and then Jim Brown, our President and CEO, will provide an update on our programs. We will then open up the call for a question-and-answer session.

Before beginning, I would like to remind you of our safe harbor statement. During the course of this call, we may make forward-looking statements regarding DURECT's products and development, expected product benefits, our development plans, future clinical trials or projected financial results. These forward-looking statements involve risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot